Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4489 USD | -0.34% |
|
-4.39% | -35.96% |
05-10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Immunotherapies for Cancer
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +14.80% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States, Germany, United Kingdom and Netherlands
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +14.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 68 | 16/05/07 |
Alton Boynton
FOU | Founder | 79 | 17/03/96 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 31/12/99 |
David Innes
IRC | Investor Relations Contact | - | 25/02/19 |
Leslie Goldman
LAW | General Counsel | 78 | 31/05/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alton Boynton
FOU | Founder | 79 | 17/03/96 |
Linda Powers
CEO | Chief Executive Officer | 68 | 16/05/07 |
Navid Malik
BRD | Director/Board Member | 55 | 31/03/12 |
Joseph Black
BRD | Director/Board Member | 74 | 26/01/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,300,000 | 0 | 0 | 90.84 % |
Stock B | 1 | 1,210,879,427 | 1,099,989,992 ( 90.84 %) | 0 |
Company contact information
Northwest Biotherapeutics, Inc.
4800 Montgomery Lane Suite 800
20814, Bethesda
+240 497 9024
http://www.nwbio.com![address Northwest Biotherapeutics, Inc.(NWBO)](https://cdn.zonebourse.com/static/address/120787357.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-35.96% | 552M | |
+16.45% | 122B | |
+21.96% | 116B | |
+24.31% | 27.03B | |
-20.05% | 20.36B | |
-16.61% | 16.43B | |
-16.28% | 15.91B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- NWBO Stock
- Company Northwest Biotherapeutics, Inc.